Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00130221 · ClinicalTrials.gov registry record · Phase 1
Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections
A Phase 1 study of Sepsis and Pneumonia, sponsored by Cook County Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 208
- Enrollment target
- 1
- Study location
NCT00130221 is a Phase 1 study of Sepsis and Pneumonia that has completed, run by Cook County Health. The registered enrollment target is 208 participants, below the 6,562-participant average among 90 other Sepsis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00130221, a Phase 1 study of Sepsis and Pneumonia, has completed, sponsored by Cook County Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 208 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients in the intensive care unit are at risk for many infections because the severity of illness and the procedures necessary to care for them. This study is designed to look at a change in bathing procedure as a method to reduce infections. Currently, patients at John H. Stroger Hospital are cleansed with soap and water. However, preliminary data from a previous study at Rush University Medical Center showed that a chlorhexidine (CHG)-impregnated cloth (2% CHG Antiseptic Cloth system, Sage Products, Inc.) decreased skin bacteria and may lessen bacteria in the blood stream. The 2% CHG Antiseptic Cloth system is a non-irritating, no-rinse, cleansing and moisturizing product that contains 2% chlorhexidine gluconate. The goal of this proposed study is to further evaluate the effectiveness of the 2% CHG Antiseptic Cloth system compared with soap and water in cleansing the skin and preventing bacteria from entering the bloodstream.
Conditions Studied
Interventions
- DRUG 2% chlorhexidine gluconate impregnated cloth
- OTHER Daily bathing with Bar soap
Study Locations (1)
Illinois
- John H. Stroger Hospital of Cook County - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-07-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00130221
The ClinicalTrials.gov registry entry for NCT00130221 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,562-participant average among 90 other Sepsis trials with a reported enrollment target (97% lower). The listed sponsor is Cook County Health, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Sepsis appearing as the primary indexed condition, and to 2 interventions - of which 2% chlorhexidine gluconate impregnated cloth is the first listed.
NCT00130221 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00130221 about?
NCT00130221 is a clinical study titled "Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections". Patients in the intensive care unit are at risk for many infections because the severity of illness and the procedures necessary to care for them. This study is designed to look at a change in bathing procedure as a method to reduce infections. Currently, patients at John H. Stroger Hospital are cle...
What is the current status of trial NCT00130221?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 208 participants. The study started on 2005-06. Estimated completion is 2006-07-26.
What conditions does trial NCT00130221 study?
This clinical trial studies the following conditions: Sepsis, Pneumonia, Urinary Tract Infection, Bacteremia, Nosocomial Infection.
What interventions are being tested in trial NCT00130221?
The interventions under investigation include: 2% chlorhexidine gluconate impregnated cloth (DRUG), Daily bathing with Bar soap (OTHER).
Who is sponsoring clinical trial NCT00130221?
This trial is sponsored by Cook County Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00130221 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention
RECRUITING · Phase 1
-
Safety Study of Inhaled Carbon Monoxide to Treat Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
ACTIVE NOT RECRUITING · Phase 1
-
Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance
COMPLETED · Phase 1
-
Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
COMPLETED · Phase 1
-
Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome
COMPLETED · Phase 1
-
The APS Phenotyping Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.